How Provider Status Would Change Independent Pharmacy Practice

Dan Benamoz, RPh, president and CEO of Pharmacy Development Services, talks about how provider status could change independent pharmacy practice.

Dan Benamoz, RPh, president and CEO of Pharmacy Development Services, talks about how provider status could change independent pharmacy practice.

This interview was recorded at the Pharmacy Development Services 2015 conference in Orlando, Florida.

Related Videos
View All
Related Content

COVID-19 Public Health Measures May Have Lowered Cases of Respiratory Syncytial Virus

January 26th 2023

Pharmacy Focus: Student Edition - Career in PBMs

January 23rd 2023

Managing Patient Expectations May Improve Treatment of Anxiety, Depression

January 26th 2023

BONUS: Public Health Matters - Highlighting Women of Color in Pharmacy

January 19th 2023

Study Results Link COVID-19 to Higher Risk of Cardiovascular Disease, Death

January 26th 2023

FDA to Review Application for Empagliflozin for Adults with Chronic Kidney Disease

January 26th 2023

COVID-19 Public Health Measures May Have Lowered Cases of Respiratory Syncytial Virus

January 26th 2023

Pharmacy Focus: Student Edition - Career in PBMs

January 23rd 2023

Managing Patient Expectations May Improve Treatment of Anxiety, Depression

January 26th 2023

BONUS: Public Health Matters - Highlighting Women of Color in Pharmacy

January 19th 2023

Study Results Link COVID-19 to Higher Risk of Cardiovascular Disease, Death

January 26th 2023

FDA to Review Application for Empagliflozin for Adults with Chronic Kidney Disease

January 26th 2023

COVID-19 Public Health Measures May Have Lowered Cases of Respiratory Syncytial Virus

January 26th 2023

Pharmacy Focus: Student Edition - Career in PBMs

January 23rd 2023

Managing Patient Expectations May Improve Treatment of Anxiety, Depression

January 26th 2023

BONUS: Public Health Matters - Highlighting Women of Color in Pharmacy

January 19th 2023

Study Results Link COVID-19 to Higher Risk of Cardiovascular Disease, Death

January 26th 2023

FDA to Review Application for Empagliflozin for Adults with Chronic Kidney Disease

January 26th 2023
About Us
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.